MMC
62
-5
TAP
53
2
FTI
76
8
SEE
36
2
KMB
40
-4
VRSK
38
-2
HST
52
3
EQIX
60
-3
HCA
70
-3
PNW
66
-3
NDAQ
59
-3
GE
82
-2
DHR
56
-4
AAP
23
2
MA
69
2
EW
16
-9
BSX
69
-2
FE
50
-7
CCL
67
2
MMM
50
-2
MMC
62
-5
TAP
53
2
FTI
76
8
SEE
36
2
KMB
40
-4
VRSK
38
-2
HST
52
3
EQIX
60
-3
HCA
70
-3
PNW
66
-3
NDAQ
59
-3
GE
82
-2
DHR
56
-4
AAP
23
2
MA
69
2
EW
16
-9
BSX
69
-2
FE
50
-7
CCL
67
2
MMM
50
-2
Financhill
Back

Cellectar Biosciences 10K Form

Sell
44

CLRB
Cellectar Biosciences

Last Price:
2.11
Seasonality Move:
-15.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLRB News And Ratings

See the #1 stock for the next 7 days that we like better than CLRB

CLRB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-13.38M
Price / Cash Flow: 0
Annual Sales: $0.27
Price / Book: 8.32

Profitability

EPS (TTM): -3.08000
Net Income (TTM): $-50.98M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Cellectar Biosciences Earnings Forecast

Key Cellectar Biosciences Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 16 years.

Cellectar Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLRB
CUSIP: 15117F
Website: cellectar.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLRB Technical Analysis vs Fundamental Analysis

Sell
44
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy or a Sell?